共 4 条
第81届美国糖尿病协会(ADA)年会会议纪要:糖尿病及其他代谢性疾病学术进展
被引:4
作者:

李光善
论文数: 0 引用数: 0
h-index: 0
机构:
青岛大学附属青岛市海慈医院内分泌科 青岛大学附属青岛市海慈医院内分泌科

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:
机构:
[1] 青岛大学附属青岛市海慈医院内分泌科
[2] 南昌大学第一附属医院内分泌科
来源:
关键词:
糖尿病;
代谢性疾病;
美国糖尿病协会年会;
D O I:
暂无
中图分类号:
R587.1 [糖尿病];
R589 [代谢病];
学科分类号:
100201 [内科学];
摘要:
美国糖尿病协会(American Diabetes Association, ADA)第81届科学年会于2021年6月25至29日在线召开, 本次大会主要涵盖了糖尿病急慢性并发症、行为医学、临床营养学、教育和运动、临床糖尿病/治疗、流行病学/遗传学、免疫学/移植、胰岛素作用/分子代谢、综合生理学/肥胖和胰岛生物学/胰岛素分泌等多个主题, 内容涉及糖尿病及其他代谢性疾病的基础与临床研究等多个方面, 现就该领域的学术进展要点进行概述。
引用
收藏
相关论文
共 4 条
[1]
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
[J].
Holt, Richard I. G.
;
DeVries, J. Hans
;
Hess-Fischl, Amy
;
Hirsch, Irl B.
;
Kirkman, M. Sue
;
Klupa, Tomasz
;
Ludwig, Barbara
;
Norgaard, Kirsten
;
Pettus, Jeremy
;
Renard, Eric
;
Skyler, Jay S.
;
Snoek, Frank J.
;
Weinstock, Ruth S.
;
Peters, Anne L.
.
DIABETES CARE,
2021, 44 (11)
:2589-2625

论文数: 引用数:
h-index:
机构:

DeVries, J. Hans
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Amsterdam, Amsterdam UMC, Internal Med, Amsterdam, Netherlands
Profil Inst Metab Res, Neuss, Germany Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, Hants, England

论文数: 引用数:
h-index:
机构:

Hirsch, Irl B.
论文数: 0 引用数: 0
h-index: 0
机构:
UW Med Diabet Inst, Seattle, WA USA Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, Hants, England

Kirkman, M. Sue
论文数: 0 引用数: 0
h-index: 0
机构:
Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, Hants, England

论文数: 引用数:
h-index:
机构:

Ludwig, Barbara
论文数: 0 引用数: 0
h-index: 0
机构:
Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, Hants, England

论文数: 引用数:
h-index:
机构:

Pettus, Jeremy
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calif San Diego, San Diego, CA 92103 USA Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, Hants, England

论文数: 引用数:
h-index:
机构:

Skyler, Jay S.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Miller Sch Med, Miami, FL 33136 USA Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, Hants, England

Snoek, Frank J.
论文数: 0 引用数: 0
h-index: 0
机构:
Vrije Univ, Amsterdam UMC, Med Psychol, Amsterdam, Netherlands Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, Hants, England

Weinstock, Ruth S.
论文数: 0 引用数: 0
h-index: 0
机构:
SUNY Upstate Med Univ, Syracuse, NY 13210 USA Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, Hants, England

Peters, Anne L.
论文数: 0 引用数: 0
h-index: 0
机构:
Keck Sch Med USC, Los Angeles, CA USA Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, Hants, England
[2]
IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose phase 1b study
[J].
Ji, Linong
;
Jiang, Hongwei
;
An, Pei
;
Deng, Huan
;
Liu, Meng
;
Li, Li
;
Feng, Liqi
;
Song, Baili
;
Han-Zhang, Han
;
Ma, Qingyang
;
Qian, Lei
.
ECLINICALMEDICINE,
2021, 39

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

An, Pei
论文数: 0 引用数: 0
h-index: 0
机构:
Innovent Biol, Suzhou, Peoples R China Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing, Peoples R China

Deng, Huan
论文数: 0 引用数: 0
h-index: 0
机构:
Innovent Biol, Suzhou, Peoples R China Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing, Peoples R China

Liu, Meng
论文数: 0 引用数: 0
h-index: 0
机构:
Innovent Biol, Suzhou, Peoples R China Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing, Peoples R China

Li, Li
论文数: 0 引用数: 0
h-index: 0
机构:
Innovent Biol, Suzhou, Peoples R China Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing, Peoples R China

Feng, Liqi
论文数: 0 引用数: 0
h-index: 0
机构:
Innovent Biol, Suzhou, Peoples R China Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing, Peoples R China

Song, Baili
论文数: 0 引用数: 0
h-index: 0
机构:
Innovent Biol, Suzhou, Peoples R China Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing, Peoples R China

Han-Zhang, Han
论文数: 0 引用数: 0
h-index: 0
机构:
Innovent Biol, Suzhou, Peoples R China Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing, Peoples R China

Ma, Qingyang
论文数: 0 引用数: 0
h-index: 0
机构:
Innovent Biol, Suzhou, Peoples R China Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing, Peoples R China

Qian, Lei
论文数: 0 引用数: 0
h-index: 0
机构:
Innovent Biol, Suzhou, Peoples R China Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing, Peoples R China
[3]
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
[J].
Ludvik, Bernhard
;
Giorgino, Francesco
;
Jodar, Esteban
;
Frias, Juan P.
;
Fernandez Lando, Laura
;
Brown, Katelyn
;
Bray, Ross
;
Rodriguez, Angel
.
LANCET,
2021, 398 (10300)
:583-598

Ludvik, Bernhard
论文数: 0 引用数: 0
h-index: 0
机构:
Vienna Hlth Assoc, Landstrasse Clin, Med Dept 1, Vienna, Austria
Vienna Hlth Assoc, Landstrasse Clin, Karl Landsteiner Inst Obes & Metab Disorders, Vienna, Austria Vienna Hlth Assoc, Landstrasse Clin, Med Dept 1, Vienna, Austria

论文数: 引用数:
h-index:
机构:

Jodar, Esteban
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Europea, Hosp Univ Quironsalud Madrid, Madrid, Spain Vienna Hlth Assoc, Landstrasse Clin, Med Dept 1, Vienna, Austria

Frias, Juan P.
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Res Inst, Los Angeles, CA USA Vienna Hlth Assoc, Landstrasse Clin, Med Dept 1, Vienna, Austria

Fernandez Lando, Laura
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA Vienna Hlth Assoc, Landstrasse Clin, Med Dept 1, Vienna, Austria

Brown, Katelyn
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA Vienna Hlth Assoc, Landstrasse Clin, Med Dept 1, Vienna, Austria

Bray, Ross
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA Vienna Hlth Assoc, Landstrasse Clin, Med Dept 1, Vienna, Austria

Rodriguez, Angel
论文数: 0 引用数: 0
h-index: 0
机构:
Lilly Spain, Madrid 28108, Spain Vienna Hlth Assoc, Landstrasse Clin, Med Dept 1, Vienna, Austria
[4]
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
[J].
Rosenstock, Julio
;
Wysham, Carol
;
Frias, Juan P.
;
Kaneko, Shizuka
;
Lee, Clare J.
;
Lando, Laura Fernandez
;
Mao, Huzhang
;
Cui, Xuewei
;
Karanikas, Chrisanthi A.
;
Thieu, Vivian T.
.
LANCET,
2021, 398 (10295)
:143-155

Rosenstock, Julio
论文数: 0 引用数: 0
h-index: 0
机构:
Dallas Diabet Res Ctr Med City, Dallas, TX 75230 USA Dallas Diabet Res Ctr Med City, Dallas, TX 75230 USA

Wysham, Carol
论文数: 0 引用数: 0
h-index: 0
机构:
MultiCare Rockwood Clin, Spokane, WA USA Dallas Diabet Res Ctr Med City, Dallas, TX 75230 USA

Frias, Juan P.
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Res Inst, Los Angeles, CA USA Dallas Diabet Res Ctr Med City, Dallas, TX 75230 USA

Kaneko, Shizuka
论文数: 0 引用数: 0
h-index: 0
机构:
Takatsuki Red Cross Hosp, Osaka, Japan Dallas Diabet Res Ctr Med City, Dallas, TX 75230 USA

Lee, Clare J.
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA Dallas Diabet Res Ctr Med City, Dallas, TX 75230 USA

Lando, Laura Fernandez
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA Dallas Diabet Res Ctr Med City, Dallas, TX 75230 USA

Mao, Huzhang
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA Dallas Diabet Res Ctr Med City, Dallas, TX 75230 USA

Cui, Xuewei
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA Dallas Diabet Res Ctr Med City, Dallas, TX 75230 USA

Karanikas, Chrisanthi A.
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA Dallas Diabet Res Ctr Med City, Dallas, TX 75230 USA

Thieu, Vivian T.
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA Dallas Diabet Res Ctr Med City, Dallas, TX 75230 USA
